|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 26, No 26 (September 10), 2008: pp. 4347-4352 © 2008 American Society of Clinical Oncology. DOI: 10.1200/JCO.2007.15.5291
Racial Composition of Hospitals: Effects on Surgery for Early-Stage Non–Small-Cell Lung Cancer
From the Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Corresponding author: Christopher S. Lathan, MD, MS, MPH, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, 44 Binney St, 454-STE 21-24, Boston, MA 02115; e-mail: christopher_lathan{at}dfci.harvard.edu Purpose Black patients undergo potentially curative surgery for early-stage lung cancer at a lower rate when compared with white patients. Our study examines the relationship between the percentage of black patients treated at a hospital to determine whether it affects the likelihood of obtaining cancer-directed surgery for patients with non–small-cell lung cancer (NSCLC).
Patients and Methods We examined claims data of Medicare-eligible patients with nonmetastatic NSCLC living in areas monitored by the Surveillance, Epidemiology, and End Results program between 1991 and 2001. Hospitals were categorized by the percentage of black patients seen:
Results Among 9,688 patients with NSCLC, 59% of white patients were seen at a hospital that had Conclusion Our study results indicate that patient and hospital characteristics are significant predictors of undergoing surgery for Medicare beneficiaries with localized lung cancer. Further examination of the role of the patient-, provider-, and hospital-level factors, in association with the decision to pursue surgical treatment of localized lung cancers, is needed. Supported by National Cancer Institute Grant No. KO1 CA124581-01A (C.S.L.) and the National Cancer Institute funded Program in Cancer Outcomes Research Training (Grant No. 5R25 CA092203-04). Presented in part at the 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, FL. Authors disclosures of potential conflicts of interest and author contributions are found at the end of this article.
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|